Cargando…

Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors

PURPOSE: The purpose of the study is to investigate the inhibition of hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors by liposomal curcumin. MATERIALS AND METHODS: A total of 54 VX2 rabbits were divided into three groups, and each group had three subgroups according to the...

Descripción completa

Detalles Bibliográficos
Autores principales: Dai, Feng, Zhang, Xiuming, Shen, Wenrong, Chen, Jun, Liu, Liucheng, Gao, Gejun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592055/
https://www.ncbi.nlm.nih.gov/pubmed/26451117
http://dx.doi.org/10.2147/OTT.S87931
_version_ 1782393155984818176
author Dai, Feng
Zhang, Xiuming
Shen, Wenrong
Chen, Jun
Liu, Liucheng
Gao, Gejun
author_facet Dai, Feng
Zhang, Xiuming
Shen, Wenrong
Chen, Jun
Liu, Liucheng
Gao, Gejun
author_sort Dai, Feng
collection PubMed
description PURPOSE: The purpose of the study is to investigate the inhibition of hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors by liposomal curcumin. MATERIALS AND METHODS: A total of 54 VX2 rabbits were divided into three groups, and each group had three subgroups according to the sacrifice time. The animals in the control group (n=18) underwent sham embolization. Transcatheter arterial embolization (TAE)-treated group (n=18) animals underwent embolization with lipiodol (0.1 mL/kg body weight) and 90–180 µm polyvinyl alcohol (PVA) particles. Liposomal curcumin TAE-treated group (n=18) animals underwent embolization with liposomal curcumin (20 mg/kg body weight) mixed with lipiodol (0.1 mL/kg body weight) and 90–180 µm PVA particles. After embolization, the animals in each subgroup were sacrificed at 6 hours, 24 hours, and 3 days, and the tumor samples were collected. Immunohistochemical staining was performed to evaluate expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) proteins, and microvessel density (MVD). Real-time polymerase chain reaction was performed to examine VEGF mRNA levels. RESULTS: The levels of HIF-1α and VEGF, and MVD in tumors of liposomal curcumin TAE-treated group were significantly decreased compared to the TAE-treated group (P<0.05). There was a slight decrease in tumor size in the liposomal curcumin TAE-treated group at third-day time points compared to the TAE-treated group; the difference was not statistically significant (P>0.05). The HIF-1α protein correlated considerably with VEGF mRNA (r=0.705, P=0.001) and protein (r=0.655, P=0.003), and MVD (r=0.521, P=0.027). A significant correlation between VEGF protein and MVD was noted as well (r=0.519, P=0.027). CONCLUSION: Liposomal curcumin downregulates HIF-1α protein levels and inhibits hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors.
format Online
Article
Text
id pubmed-4592055
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-45920552015-10-08 Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors Dai, Feng Zhang, Xiuming Shen, Wenrong Chen, Jun Liu, Liucheng Gao, Gejun Onco Targets Ther Original Research PURPOSE: The purpose of the study is to investigate the inhibition of hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors by liposomal curcumin. MATERIALS AND METHODS: A total of 54 VX2 rabbits were divided into three groups, and each group had three subgroups according to the sacrifice time. The animals in the control group (n=18) underwent sham embolization. Transcatheter arterial embolization (TAE)-treated group (n=18) animals underwent embolization with lipiodol (0.1 mL/kg body weight) and 90–180 µm polyvinyl alcohol (PVA) particles. Liposomal curcumin TAE-treated group (n=18) animals underwent embolization with liposomal curcumin (20 mg/kg body weight) mixed with lipiodol (0.1 mL/kg body weight) and 90–180 µm PVA particles. After embolization, the animals in each subgroup were sacrificed at 6 hours, 24 hours, and 3 days, and the tumor samples were collected. Immunohistochemical staining was performed to evaluate expression of hypoxia-inducible factor-1α (HIF-1α) and vascular endothelial growth factor (VEGF) proteins, and microvessel density (MVD). Real-time polymerase chain reaction was performed to examine VEGF mRNA levels. RESULTS: The levels of HIF-1α and VEGF, and MVD in tumors of liposomal curcumin TAE-treated group were significantly decreased compared to the TAE-treated group (P<0.05). There was a slight decrease in tumor size in the liposomal curcumin TAE-treated group at third-day time points compared to the TAE-treated group; the difference was not statistically significant (P>0.05). The HIF-1α protein correlated considerably with VEGF mRNA (r=0.705, P=0.001) and protein (r=0.655, P=0.003), and MVD (r=0.521, P=0.027). A significant correlation between VEGF protein and MVD was noted as well (r=0.519, P=0.027). CONCLUSION: Liposomal curcumin downregulates HIF-1α protein levels and inhibits hypoxia-induced angiogenesis after embolization in VX2 rabbit liver tumors. Dove Medical Press 2015-09-15 /pmc/articles/PMC4592055/ /pubmed/26451117 http://dx.doi.org/10.2147/OTT.S87931 Text en © 2015 Dai et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Dai, Feng
Zhang, Xiuming
Shen, Wenrong
Chen, Jun
Liu, Liucheng
Gao, Gejun
Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_full Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_fullStr Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_full_unstemmed Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_short Liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in VX2 rabbit liver tumors
title_sort liposomal curcumin inhibits hypoxia-induced angiogenesis after transcatheter arterial embolization in vx2 rabbit liver tumors
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4592055/
https://www.ncbi.nlm.nih.gov/pubmed/26451117
http://dx.doi.org/10.2147/OTT.S87931
work_keys_str_mv AT daifeng liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT zhangxiuming liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT shenwenrong liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT chenjun liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT liuliucheng liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors
AT gaogejun liposomalcurcumininhibitshypoxiainducedangiogenesisaftertranscatheterarterialembolizationinvx2rabbitlivertumors